China said on Thursday that it would strengthen the competitiveness of its dominant rare earths industry in the next five years, according to its 15th Five-Year Plan. The world’s largest producer of ...
New research by Cleveland Clinic and Dyania Health demonstrates how a medically trained large language model system can accurately and efficiently screen electronic medical records (EMRs) to identify ...
NEW YORK, March 3, 2026 /PRNewswire/ -- REalloys (ALOY) and a small number of other North American companies are doing what the rest of the Western world failed to do for three decades: They are ...
Pokémon Go is set to celebrate 30 years of Pokémon with rare encounters, Legendary raids, a web shop tie-in and more. The geolocation title was highlighted during Pokémon Day on February 27th, 2026, ...
In a typical Chinese rare earth processing plant, 200 workers move through a maze of massive chemical tanks, risking life and limb to produce the materials that power everything from fighter jets and ...
A 35-year-old woman presents to her primary care physician with a 1-month history of an enlarging, nontender left axillary mass. Case by Dr Maurie Markman.
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump listens as Dr. Marty Makary ...
The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed ...
The U.S. is developing a Western price floor mechanism for rare earths to reduce reliance on China’s pricing system. Rising Chinese PrNd prices—now above $125/kg—highlight Western vulnerability, as ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
The FDA has released draft guidance outlining an approval pathway for individualized therapies aimed at ultra-rare diseases, building on a framework first outlined by agency leaders in November. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results